67 related articles for article (PubMed ID: 12857389)
1. A FlashPlate assay for the identification of PARP-1 inhibitors.
Dillon KJ; Smith GC; Martin NM
J Biomol Screen; 2003 Jun; 8(3):347-52. PubMed ID: 12857389
[TBL] [Abstract][Full Text] [Related]
2. A scintillation proximity assay for poly(ADP-ribose) polymerase.
Cheung A; Zhang J
Anal Biochem; 2000 Jun; 282(1):24-8. PubMed ID: 10860495
[TBL] [Abstract][Full Text] [Related]
3. An enzymatic assay for poly(ADP-ribose) polymerase-1 (PARP-1) via the chemical quantitation of NAD(+): application to the high-throughput screening of small molecules as potential inhibitors.
Putt KS; Hergenrother PJ
Anal Biochem; 2004 Mar; 326(1):78-86. PubMed ID: 14769338
[TBL] [Abstract][Full Text] [Related]
4. Chain length analysis of ADP-ribose polymers generated by poly(ADP-ribose) polymerase (PARP) as a function of beta-NAD+ and enzyme concentrations.
Mendoza-Alvarez H; Chavez-Bueno S; Alvarez-Gonzalez R
IUBMB Life; 2000 Aug; 50(2):145-9. PubMed ID: 11185961
[TBL] [Abstract][Full Text] [Related]
5. Development of a high-throughput screening-amenable assay for human poly(ADP-ribose) polymerase inhibitors.
Brown JA; Marala RB
J Pharmacol Toxicol Methods; 2002; 47(3):137-41. PubMed ID: 12628304
[TBL] [Abstract][Full Text] [Related]
6. A nonradiometric, high-throughput assay for poly(ADP-ribose) glycohydrolase (PARG): application to inhibitor identification and evaluation.
Putt KS; Hergenrother PJ
Anal Biochem; 2004 Oct; 333(2):256-64. PubMed ID: 15450800
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel poly(ADP-ribose) glycohydrolase inhibitors by a quantitative assay system using dot-blot with anti-poly(ADP-ribose).
Okita N; Ashizawa D; Ohta R; Abe H; Tanuma S
Biochem Biophys Res Commun; 2010 Feb; 392(4):485-9. PubMed ID: 20079708
[TBL] [Abstract][Full Text] [Related]
8. Differential contribution of poly(ADP-ribose)polymerase-1 and -2 (PARP-1 and -2) to the poly(ADP-ribosyl)ation reaction in rat primary spermatocytes.
Tramontano F; Malanga M; Quesada P
Mol Hum Reprod; 2007 Nov; 13(11):821-8. PubMed ID: 17766683
[TBL] [Abstract][Full Text] [Related]
9. Development of a miniaturized assay for the high-throughput screening program for poly(ADP-ribose) polymerase-1.
Lee S; Koo HN; Lee BH
Methods Find Exp Clin Pharmacol; 2005 Nov; 27(9):617-22. PubMed ID: 16357945
[TBL] [Abstract][Full Text] [Related]
10. The mechanism of the elongation and branching reaction of poly(ADP-ribose) polymerase as derived from crystal structures and mutagenesis.
Ruf A; Rolli V; de Murcia G; Schulz GE
J Mol Biol; 1998 Apr; 278(1):57-65. PubMed ID: 9571033
[TBL] [Abstract][Full Text] [Related]
11. Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors.
Orvieto F; Branca D; Giomini C; Jones P; Koch U; Ontoria JM; Palumbi MC; Rowley M; Toniatti C; Muraglia E
Bioorg Med Chem Lett; 2009 Aug; 19(15):4196-200. PubMed ID: 19541484
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of poly(ADP-ribose) polymerase (PARP) influences the mode of sulfur mustard (SM)-induced cell death in HaCaT cells.
Kehe K; Raithel K; Kreppel H; Jochum M; Worek F; Thiermann H
Arch Toxicol; 2008 Jul; 82(7):461-70. PubMed ID: 18046540
[TBL] [Abstract][Full Text] [Related]
13. Identification of aminoethyl pyrrolo dihydroisoquinolinones as novel poly(ADP-ribose) polymerase-1 inhibitors.
Branca D; Cerretani M; Jones P; Koch U; Orvieto F; Palumbi MC; Rowley M; Toniatti C; Muraglia E
Bioorg Med Chem Lett; 2009 Aug; 19(15):4042-5. PubMed ID: 19553107
[TBL] [Abstract][Full Text] [Related]
14. The inhibition of poly(ADP-ribose) polymerase enhances growth rates of ataxia telangiectasia cells.
Marecki JC; McCord JM
Arch Biochem Biophys; 2002 Jun; 402(2):227-34. PubMed ID: 12051667
[TBL] [Abstract][Full Text] [Related]
15. Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.
Pogrebniak A; Schemainda I; Pelka-Fleischer R; Nüssler V; Hasmann M
Eur J Med Res; 2003 Oct; 8(10):438-50. PubMed ID: 14594650
[TBL] [Abstract][Full Text] [Related]
16. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
[TBL] [Abstract][Full Text] [Related]
17. Oxidant-induced cardiomyocyte injury: identification of the cytoprotective effect of a dopamine 1 receptor agonist using a cell-based high-throughput assay.
Gerö D; Módis K; Nagy N; Szoleczky P; Tóth ZD; Dormán G; Szabó C
Int J Mol Med; 2007 Nov; 20(5):749-61. PubMed ID: 17912470
[TBL] [Abstract][Full Text] [Related]
18. Different basal NAD levels determine opposite effects of poly(ADP-ribosyl)polymerase inhibitors on H2O2-induced apoptosis.
Coppola S; Nosseri C; Maresca V; Ghibelli L
Exp Cell Res; 1995 Dec; 221(2):462-9. PubMed ID: 7493646
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma.
Genovese T; Mazzon E; Muià C; Patel NS; Threadgill MD; Bramanti P; De Sarro A; Thiemermann C; Cuzzocrea S
J Pharmacol Exp Ther; 2005 Feb; 312(2):449-57. PubMed ID: 15452194
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribose) polymerase cleavage during apoptosis: when and where?
Soldani C; Lazzè MC; Bottone MG; Tognon G; Biggiogera M; Pellicciari CE; Scovassi AI
Exp Cell Res; 2001 Oct; 269(2):193-201. PubMed ID: 11570811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
